SEC Filings TLDR

RA Capital Nexus Fund, L.P., a director and 10% stockholder of Sionna Therapeutics, Inc., has filed a Form 144 indicating its intent to sell 122,271 shares of common stock. The shares were acquired on September 18, 2020, through a private transaction. The planned sale is expected to occur on October 24, 2025, with an a...

RA Capital Nexus Fund III, L.P., a 10% stockholder and director of Sionna Therapeutics, Inc., has filed a Form 144 notice indicating its intent to sell 66,672 shares of common stock. The shares were acquired during the company's IPO on February 7, 2025. The sale is expected to take place on or around October 24, 2025, ...

RA Capital Healthcare Fund LP, a director and 10% stockholder of Sionna Therapeutics, Inc., has filed a Form 144 notice indicating its intent to sell 14,116 shares of Sionna Therapeutics common stock. The shares were acquired on February 2, 2022, through a private transaction. The planned sale is expected to occur on O...

Blackwell Partners LLC - Series A, a 10% stockholder and director of Sionna Therapeutics, Inc., has filed a Form 144 with the SEC indicating its intent to sell 107,941 common shares of Sionna Therapeutics. The shares were acquired on September 18, 2020, through a private transaction. The approximate sale date is set fo...

Neil Mitchill Jr., an officer of RTX CORP, has sold 4,849 shares of the company's common stock on October 24, 2025. The shares were acquired through the exercise of Stock Appreciation Rights (SARs) and were sold at an aggregate market value of $873,527. The transaction was executed through UBS Financial Services Inc. T...

Tracy A. Atkinson, a director at RTX Corp, has filed a Form 144 indicating the intent to sell 2,800 shares of common stock. The shares were acquired through stock awards on April 8, 2020, and May 26, 2016. The approximate sale date is set for October 24, 2025, with an aggregate market value of $501,200. The sale will b...

The filing details securities transactions involving THE WOOD REVOCABLE TRUST U/A DTD 12/01/2017, associated with Roku, Inc. Director, Officer, and 10% Stockholder Anthony John Wood. The trust plans to sell 3,400 shares of Common stock acquired through the exercise of stock options on 10/24/2025. Additionally, the fili...

The filing details the securities transactions of Matthew Doctor, a former officer and director of Regis Corp. It includes the sale of 704 common shares on 10/24/2025, with an aggregate market value of $21,472.00. Additionally, the filing reports multiple sales of common shares in the past three months, totaling 13,742...

Friedrich Prinz, a director of QuantumScape Corporation, has filed a Form 144 notice indicating the planned sale of 1,000,000 Class A Common Stock shares. The shares are held by various trusts associated with Prinz, including the Prinz Family Trust, Benedikt F. Prinz 2019 Trust, and Marie Helene Prinz 2019 Trust. The s...

Srinivasan Sivaram, an officer of QuantumScape Corporation, filed a Form 144 with the SEC indicating the intent to sell 30,000 shares of Class A Common stock. The shares are part of restricted stock vesting under a registered plan, with 6,377 shares acquired on 08/15/2024 and 23,623 shares acquired on 02/18/2025. The a...

The filing details the securities transactions of Mohit Singh, an officer at QuantumScape Corporation. The transactions involve the vesting of restricted stock and the exercise of options under a registered plan. The securities involved are common stock, with a total of 220,000 units sold on October 24, 2025, at an agg...

On October 24, 2025, Brad Buss, a director of QuantumScape Corporation, exercised options to acquire 400,000 shares of common stock under a registered plan. The shares were acquired from the issuer, and the transaction was not a gift. The aggregate market value of the shares at the time of the transaction was approxima...

Michael McCarthy, an officer at QuantumScape Corporation, has reported several securities transactions. On 10/24/2025, he exercised options to acquire 25,000 common shares under a registered plan. Additionally, he acquired 20,000 common shares through restricted stock vesting on 05/15/2025, and 711 common shares throug...

James B. Connor, a director of Prologis, Inc., has filed a Form 144 to sell 80,000 shares of common stock acquired in a private transaction on October 23, 2025. The shares are to be sold on October 24, 2025, with an aggregate market value of approximately $10,114,400. The sale is being facilitated by Goldman Sachs & Co...

Anne McCallion, a director at PennyMac Financial Services, Inc., exercised 27,771 employee stock options on October 24, 2025. The transaction was a broker-assisted cashless exercise, resulting in the sale of the shares at an aggregate market value of $3,681,555.09. The shares were sold on the NYSE through Merrill Lynch...

Daniel Perotti, an officer of PennyMac Financial Services, Inc., has filed a Form 144 notice regarding the sale of securities. The filing details the exercise of employee stock options for 26,011 shares of common stock on October 24, 2025, with a broker-assisted cashless exercise. Additionally, the filing reports three...

Kenneth Stillwell Jr., an officer of PegaSystems Inc., filed a Form 144 with the SEC detailing the sale of securities. The filing indicates that Stillwell exercised options under a registered plan to acquire 17,171 common shares on 10/24/2025. The aggregate market value of these securities is $1,140,087.43. Additionall...

The B. Thomas Golisano Revocable Living Trust, a 10% stock owner of Paychex Inc, has filed a notice of sale of 302,050 shares of Paychex Inc common stock. The shares were acquired on May 23, 1996, through a private placement. The sale is scheduled to occur on October 24, 2025, with an aggregate market value of $37,825,...

The filing details the stock award transactions for Nadia Dombrowski, an officer at Pathward Financial, Inc. The transactions involve the acquisition of common stock as part of compensation. The securities were acquired on multiple dates: 09/30/2022 (518 shares), 10/16/2023 (1,152 shares), 09/30/2024 (259 shares), 10/1...

Anthony M. Sharett, an officer of Pathward Financial, Inc., has filed a Form 144 notice indicating the intent to sell 11,500 shares of common stock held in The Celise Living Trust account. The shares were acquired through stock awards between September 2022 and October 2023. The approximate sale date is set for October...

The filing details the securities transactions of Michael Brophy, an officer of Natera, Inc. Brophy plans to sell 755 Common Stock units acquired through Restricted Stock Units on 10/22/2025. The aggregate market value of these securities is $147,225.00. Additionally, the filing reports Brophy's recent securities sales...

Jen-Hsun Huang, President and CEO of NVIDIA Corp, has filed a notice of intent to sell 75,000 shares of common stock. The shares were acquired on September 21, 2022, as part of a performance stock lapse under an equity compensation plan. The notice was filed on October 24, 2025, with the plan adopted on March 20, 2025....

Avishai Vaknin, the Chief Technology Officer (CTO) of NEXTNRG, INC., has filed a Form 144 with the SEC. The filing indicates that Vaknin plans to sell 64,713 shares of common stock, which were acquired through an employment agreement with EzFill Holdings Inc. The shares were acquired on April 19, 2023, and the approxim...

Saria Tseng, an officer at Monolithic Power Systems, Inc., has filed a Form 144 notice detailing her securities transactions. The filing indicates that Tseng plans to sell 1,301 common shares acquired as performance shares on May 7, 2024, with an approximate sale date of October 24, 2025. The aggregate market value of ...

Michael Kliger, an officer of Luxexperience B.V., has filed a Form 144 notice indicating his intention to sell a significant amount of the company's common stock. The securities to be sold include 1,859,711 shares acquired through the exercise of stock options and 228,195 shares from vested restricted stock units. The ...